The drugs industry closed the day up 3%. OxiGene Inc ( OXGN), China Shenghuo Pharmaceutical Holdings Inc ( KUN), Novogen ( NVGN), and EntreMed Inc ( ENMD) were all decliners today within the drugs industry with Regeneron Pharmaceuticals Inc ( REGN) being today's featured drugs loser. Regeneron Pharmaceuticals Inc fell $1.44 (-2.3%) to $60.73 on average volume. Throughout the day, 1.2 million shares of Regeneron Pharmaceuticals Inc exchanged hands as compared to its average daily volume of 1.4 million shares.

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. Regeneron Pharmaceuticals Inc has a market cap of $5.6 billion and is part of the health care sector. Shares are up 89.4% year to date as of the close of trading on Friday.

TheStreet Ratings rates Regeneron as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity.

On the positive front, Adolor Corporation ( ADLR), Tibet Pharmaceuticals Inc ( TBET), Exelixis Inc ( EXEL), and Somaxon Pharmaceuticals Inc ( SOMX) were all gainers within the drugs industry with Pfizer Inc ( PFE) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).